Skip to content
You can now search across every topic, entity and event.What's new
Pandemics and Biosecurity
16JUN

Mpox strain mixes genes from two clades

2 min read
10:26UTC

WHO reported a recombinant mpox virus carrying genetic elements from both clade Ib and clade IIb, now found in four countries, with transmissibility still unknown.

ScienceDeveloping
Key takeaway

A recombinant mpox strain is a surveillance signal to track, not evidence of a more dangerous virus.

WHO's Disease Outbreak News 595 reported a recombinant mpox virus (MPXV) carrying genetic elements from both clade Ib and clade IIb 1. It was first found in a UK traveller in December 2025 and identified retrospectively in India from September 2025, and now spans at least four countries across three WHO regions 2. Mpox, formerly monkeypox, circulates in distinct lineages called clades; a recombinant carries DNA from two of them at once.

Recombination happens when two virus lineages co-infect a single host and swap genetic material. It is expected wherever clades circulate together, and detecting it is the reason genomic surveillance exists rather than evidence that surveillance has failed. The strain's appearance on the record is the system working: routine sequencing flagged a hybrid and traced it back through stored samples to September 2025. This is the kind of early signal WHO's R&D Blueprint pathogen-prioritisation programme exists to catch .

WHO calls it premature to draw any conclusion about transmissibility from so few cases, and reports no serious complications in the patients identified 3. A hybrid genome does not by itself imply a more dangerous virus, so this reads as a watch item rather than an alarm. Whether the recombinant spreads or sickens differently from its parent strains is a question only more sequencing can answer, and WHO says both sequencing and surveillance are being intensified 4.

Deep Analysis

In plain English

Mpox (formerly called monkeypox) is a virus that has two main family branches, called clades. Clade Ib has been driving an outbreak in central Africa with higher death rates in unvaccinated people. Clade IIb spread globally in 2022-2024, primarily through close physical contact, and is now widespread in many countries. Scientists have now found a version of the virus that appears to have mixed genetic material from both clades, a 'recombinant' strain. It was first spotted in a UK traveller in December 2025 and found retrospectively in India from September 2025. This is a watch item, not an alarm: the WHO found the recombinant strain in at least four countries across three regions, but reported no serious illness in identified patients and says it is too early to know if this strain spreads more easily than its parent versions. Sequencing (gene-reading of more samples) is being intensified to understand what, if anything, has changed.

First Reported In

Update #4 · Ebola triples, response misfires

World Health Organization· 24 May 2026
Read original
Different Perspectives
Chinese health authorities
Chinese health authorities
China reported three human H9N2 cases to WHO between 10 and 16 July: two four-year-olds recovered, a 44-year-old man remains in intensive care, the first severity signal in a cluster that has produced 173 cases and 2 deaths globally since 2015. The subtype is distinct from the H5N1 series this topic otherwise tracks.
US public health authorities
US public health authorities
CIDRAP and Dr Andrew Racine, president of the American Academy of Pediatrics, call 2026's 2,318 confirmed measles cases by 24 July the worst year since 1991's 2,126. Zero deaths against three in 2025 and a 7% hospitalisation rate, down from 11%, show record case counts have not brought record severity.
CEPI
CEPI
CEPI put an rVSV-platform vaccine candidate specific to Bundibugyo ebolavirus into trial-production on 31 July, developed by Hilleman Laboratories with MSD manufacturing and IAVI's reference virus, funded up to $8.5m. Eleven weeks into the third-largest Ebola outbreak on record, this is the first species-matched candidate; the licensed vaccine covers only Zaire ebolavirus.
Médecins Sans Frontières
Médecins Sans Frontières
MSF reports sexual-violence care in Ituri is almost non-existent, with 7 of 14 health centres closed or relocated by fighting, as Panzi Hospital logs 646 new survivors in six months, an 85% rise. Withdrawn US funding for post-exposure prophylaxis has left clinics across three provinces without PEP kits for months, a crisis running alongside Ebola, not caused by it.
DRC health workers at Elikya Ebola Treatment Centre
DRC health workers at Elikya Ebola Treatment Centre
Staff at DRC's Elikya Ebola Treatment Centre walked out on 25 July over unpaid wages, the second such action after Rwampara, while unconfirmed suspects occupy up to 64% of the country's isolation beds awaiting lab results. Workers are absorbing a response that has grown faster than its payroll and its labs.
Uganda's Ministry of Health
Uganda's Ministry of Health
Uganda's ministry says it discharged its last confirmed patient on 16 June, completed every contact's 21-day follow-up, and declared the country Ebola-free on 28 July, exactly 42 days later. It names Hon. Dr Chris Baryomunsi, Minister of Health, as overseeing a 20-case, 2-death outbreak it now considers closed.